Skip to content
10-Q

Quarterly Report

DARA BioSciences, Inc.

0001214659-15-003906

← back to feed
Filed
May 13, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 11, 2015 19.76M sh
Capex Q1 2015 · Mar 31, 2015 $1.24K
Operating Cash Flow Q1 2015 · Mar 31, 2015 −$2.15M
Operating Cash Flow Q1 2015 · Mar 31, 2014 −$2.06M
Cash And Equivalents Q1 2015 · Mar 31, 2015 $9.85M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $12.03M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $6.83M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $3.43M
Stockholders Equity Q1 2015 · Mar 31, 2015 $11.15M
Stockholders Equity Q1 2015 · Dec 31, 2014 $13.92M
Current Liabilities Q1 2015 · Mar 31, 2015 $3.52M
Current Liabilities Q1 2015 · Dec 31, 2014 $3.75M
Total Liabilities Q1 2015 · Mar 31, 2015 $3.61M
Total Liabilities Q1 2015 · Dec 31, 2014 $3.84M
Current Assets Q1 2015 · Mar 31, 2015 $10.95M
Current Assets Q1 2015 · Dec 31, 2014 $13.77M
Total Assets Q1 2015 · Mar 31, 2015 $14.76M
Total Assets Q1 2015 · Dec 31, 2014 $17.75M
Sga Expense Q1 2015 · Mar 31, 2015 $1.48M
Sga Expense Q1 2015 · Mar 31, 2014 $1.26M
Rd Expense Q1 2015 · Mar 31, 2015 $363.24K
Rd Expense Q1 2015 · Mar 31, 2014 $367.61K
Net Income Q1 2015 · Mar 31, 2015 −$3.15M
Operating Income Q1 2015 · Mar 31, 2015 −$3.13M
Operating Income Q1 2015 · Mar 31, 2014 −$2.91M
Cost Of Revenue Q1 2015 · Mar 31, 2015 $148.6K
Cost Of Revenue Q1 2015 · Mar 31, 2014 $53.18K
Revenue Q1 2015 · Mar 31, 2015 $652.2K
Revenue Q1 2015 · Mar 31, 2014 $161.49K